Q2 2025 · 13F-HR
DIADEMA PARTNERS LPholdings as filed
Filed 2025-08-14 · accession 0001892688-25-000149
$328.2M
Reported value
95
Positions
2025-06-30
Period end
The Brief · DIADEMA PARTNERS LP · Q2 2025
AI · grounded in 13F
DIADEMA PARTNERS LP established a new position in LLY valued at $35.5M. The fund also initiated new stakes in AMGN for $31.9M and SLNO for $23.8M. Other new additions include Jazz Pharmaceuticals PLC at $16.4M and RARE at $14.3M. The fund ended the period with 75 positions and total AUM of $328.2M.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $23.8M | 7.25% | 284,152 | Common | SOLE |
| 031162100 | AMGN | AMGEN INC | $17.3M | 5.28% | 62,100 | PUT | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $16.1M | 4.92% | 20,700 | PUT | SOLE |
| 031162100 | AMGN | AMGEN INC | $14.5M | 4.43% | 52,100 | Common | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $13.4M | 4.07% | 371,448 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $11.8M | 3.60% | 94,042 | Common | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $11.5M | 3.52% | 14,816 | Common | SOLE |
| G50871105 | JAZZ | JAZZ PHARMACEUTICALS PLC | $11.1M | 3.38% | 104,473 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $10.6M | 3.23% | 192,877 | Common | SOLE |
| 78464A870 | XBI | SPDR SERIES TRUST | $8.3M | 2.53% | 100,000 | CALL | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $7.9M | 2.40% | 217,000 | CALL | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $7.8M | 2.38% | 10,000 | CALL | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $7.4M | 2.24% | 200,000 | CALL | SOLE |
| 218352102 | CORT | CORCEPT THERAPEUTICS INC | $7.4M | 2.24% | 100,200 | PUT | SOLE |
| 670100205 | NVO | NOVO-NORDISK A S | $6.9M | 2.10% | 100,000 | CALL | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $6.8M | 2.07% | 156,300 | CALL | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $6.4M | 1.96% | 198,285 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $5.7M | 1.73% | 131,400 | CALL | SOLE |
| H17182108 | CRSP | CRISPR THERAPEUTICS AG | $5.4M | 1.66% | 112,000 | CALL | SOLE |
| G50871105 | JAZZ | JAZZ PHARMACEUTICALS PLC | $5.3M | 1.62% | 50,000 | CALL | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $5.2M | 1.59% | 197,468 | Common | SOLE |
| 82835W108 | SPRY | ARS PHARMACEUTICALS INC | $4.9M | 1.49% | 280,700 | CALL | SOLE |
| 02155H200 | ALT | ALTIMMUNE INC | $4.9M | 1.49% | 1,262,900 | CALL | SOLE |
| 717081103 | PFE | PFIZER INC | $4.8M | 1.48% | 200,000 | CALL | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $4.5M | 1.37% | 123,300 | PUT | SOLE |
| 92532F100 | VRTX | VERTEX PHARMACEUTICALS INC | $4.5M | 1.36% | 10,000 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $4.2M | 1.28% | 76,185 | Common | SOLE |
| 00847X104 | AGIO | AGIOS PHARMACEUTICALS INC | $4.1M | 1.24% | 122,100 | CALL | SOLE |
| 589492107 | MREO | MEREO BIOPHARMA GROUP PLC | $3.6M | 1.09% | 1,317,600 | CALL | SOLE |
| 75629V104 | RXRX | RECURSION PHARMACEUTICALS IN | $3.5M | 1.08% | 698,400 | CALL | SOLE |
| 375558103 | GILD | GILEAD SCIENCES INC | $3.3M | 1.01% | 30,000 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $3.3M | 1.00% | 5,974 | Common | SOLE |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $3.3M | 1.00% | 104,384 | Common | SOLE |
| 75886F107 | REGN | REGENERON PHARMACEUTICALS | $2.9M | 0.90% | 5,607 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $2.9M | 0.89% | 79,079 | Common | SOLE |
| 60770K107 | MRNA | MODERNA INC | $2.8M | 0.86% | 102,100 | CALL | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $2.8M | 0.86% | 392,213 | Common | SOLE |
| 60770K107 | MRNA | MODERNA INC | $2.8M | 0.84% | 100,000 | PUT | SOLE |
| 98985Y108 | ZYME | ZYMEWORKS INC | $2.3M | 0.69% | 179,300 | CALL | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $2.2M | 0.68% | 62,926 | Common | SOLE |
| 46565G104 | 5E7 | ITEOS THERAPEUTICS INC | $2.1M | 0.63% | 206,200 | Common | SOLE |
| M96088105 | URGN | UROGEN PHARMA LTD | $2.1M | 0.63% | 150,000 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $2.0M | 0.60% | 53,985 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $1.9M | 0.59% | 41,300 | PUT | SOLE |
| 56400P706 | MNKD | MANNKIND CORP | $1.9M | 0.59% | 519,900 | CALL | SOLE |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $1.9M | 0.58% | 88,900 | CALL | SOLE |
| 810648105 | SCPH | SCPHARMACEUTICALS INC | $1.9M | 0.56% | 486,500 | CALL | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $1.7M | 0.52% | 122,061 | Common | SOLE |
| 86627T108 | SMMT | SUMMIT THERAPEUTICS INC | $1.6M | 0.48% | 74,700 | CALL | SOLE |
| 58933Y105 | MRK | MERCK & CO INC | $1.6M | 0.48% | 20,000 | Common | SOLE |
| 76152G100 | — | REVIVA PHARMACEUTCLS HLDGS I | $1.5M | 0.46% | 4,000,000 | CALL | SOLE |
| N90064101 | QURE | UNIQURE NV | $1.5M | 0.44% | 104,100 | CALL | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $1.4M | 0.44% | 201,400 | PUT | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $1.4M | 0.43% | 100,000 | CALL | SOLE |
| 695127100 | PCRX | PACIRA BIOSCIENCES INC | $1.4M | 0.43% | 58,926 | Common | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $1.3M | 0.39% | 136,700 | CALL | SOLE |
| 68062P106 | OLMA | OLEMA PHARMACEUTICALS INC | $1.1M | 0.33% | 253,657 | Common | SOLE |
| 86627T108 | SMMT | SUMMIT THERAPEUTICS INC | $1.1M | 0.32% | 50,000 | PUT | SOLE |
| 14070B309 | CAPR | CAPRICOR THERAPEUTICS INC | $1.1M | 0.32% | 106,600 | PUT | SOLE |
| 76152G100 | — | REVIVA PHARMACEUTCLS HLDGS I | $1.0M | 0.32% | 2,735,457 | Common | SOLE |
| 60255C885 | BRD1EUR | MIND MEDICINE MINDMED INC | $1.0M | 0.31% | 158,536 | Common | SOLE |
| 09077A106 | BMEA | BIOMEA FUSION INC | $1.0M | 0.31% | 568,900 | CALL | SOLE |
| 87583X109 | TNGX | TANGO THERAPEUTICS INC | $1.0M | 0.31% | 200,000 | CALL | SOLE |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $1.0M | 0.31% | 185,830 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $1.0M | 0.31% | 824,800 | CALL | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $969,248 | 0.30% | 259,852 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $966,111 | 0.29% | 98,382 | Common | SOLE |
| 81642T209 | SLS | SELLAS LIFE SCIENCES GROUP I | $876,000 | 0.27% | 400,000 | CALL | SOLE |
| 28658R106 | CLYM | CLIMB BIO INC | $870,647 | 0.27% | 702,135 | Common | SOLE |
| 810648105 | SCPH | SCPHARMACEUTICALS INC | $829,144 | 0.25% | 217,623 | Common | SOLE |
| 92840H400 | VTGN | VISTAGEN THERAPEUTICS INC | $807,844 | 0.25% | 403,922 | Common | SOLE |
| 03152W109 | AM6 | AMICUS THERAPEUTICS INC | $752,922 | 0.23% | 131,400 | CALL | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $709,909 | 0.22% | 96,455 | Common | SOLE |
| 02155H200 | ALT | ALTIMMUNE INC | $663,318 | 0.20% | 171,400 | PUT | SOLE |
| 14147L108 | CRDF | CARDIFF ONCOLOGY INC | $655,515 | 0.20% | 208,100 | CALL | SOLE |
| 002120202 | ATYR | ATYR PHARMA INC | $652,509 | 0.20% | 128,700 | CALL | SOLE |
| G72800108 | PRTA | PROTHENA CORP PLC | $607,000 | 0.18% | 100,000 | CALL | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $600,157 | 0.18% | 160,900 | CALL | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $459,142 | 0.14% | 10,572 | Common | SOLE |
| 71722W107 | PHAT | PHATHOM PHARMACEUTICALS INC | $386,419 | 0.12% | 40,294 | Common | SOLE |
| 002120202 | ATYR | ATYR PHARMA INC | $386,334 | 0.12% | 76,200 | PUT | SOLE |
| 670703107 | NUVL | NUVALENT INC | $381,500 | 0.12% | 5,000 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $372,432 | 0.11% | 266,023 | Common | SOLE |
| N71542109 | PRQR | PROQR THRAPEUTICS N V | $321,696 | 0.10% | 157,694 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $301,767 | 0.09% | 32,483 | Common | SOLE |
| 28617K101 | ELDN | ELEDON PHARMACEUTICALS INC | $175,101 | 0.05% | 64,613 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $150,911 | 0.05% | 43,616 | Common | SOLE |
| 28623U101 | — | ELEVATION ONCOLOGY INC | $133,233 | 0.04% | 362,935 | Common | SOLE |
| 746237106 | PRTCY | PURETECH HEALTH PLC | $126,339 | 0.04% | 7,324 | Common | SOLE |
| 589492107 | MREO | MEREO BIOPHARMA GROUP PLC | $106,774 | 0.03% | 39,400 | PUT | SOLE |
| 640268306 | NKTR | NEKTAR THERAPEUTICS | $85,871 | 0.03% | 47,474 | CALL | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $49,542 | 0.02% | 6,900 | CALL | SOLE |
| 86627T108 | SMMT | SUMMIT THERAPEUTICS INC | $19,833 | 0.01% | 932 | Common | SOLE |
| 98887Q104 | ZLAB | ZAI LAB LTD | $13,236 | 0.00% | 3,785 | Common | SOLE |
| 92840H400 | VTGN | VISTAGEN THERAPEUTICS INC | $400 | 0.00% | 200 | CALL | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.